Accenture Insider Sold Shares Worth $1,866,219, According to a Recent SEC Filing-March 2024-www.financetom.com

Accenture Insider Sold Shares Worth $1,866,219, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Accenture Insider Sold Shares Worth $1,866,219, According to a Recent SEC Filing

Oct 18, 2024 7:27 AM

10:01 AM EDT, 10/18/2024 (MT Newswires) -- John F Walsh, Chief Operating Officer, on October 17, 2024, sold 5,000 shares in Accenture ( ACN ) for $1,866,219. Following the Form 4 filing with the SEC, Walsh has control over a total of 17,593 shares of the company, with 17,593 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1467373/000146737324000290/xslF345X05/wk-form4_1729256752.xml

Price: 374.26, Change: -0.89, Percent Change: -0.24

Previous page： Google to Unveil New Pixel 9 Smartphone on Aug. 13 Next page： Savara's Phase 3 Trial for Molgramostim Nebulizer Solution Meets Primary Endpoint; Shares Rise Pre-Bell

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Google to Unveil New Pixel 9 Smartphone on Aug. 13

Jun 26, 2024

07:34 AM EDT, 06/26/2024 (MT Newswires) -- Alphabet's (GOOG, GOOGL) Google ( GOOG ) unit will unveil its new Pixel 9 smartphone at an event on Aug. 13, according to a teaser posted on the company's website. Google ( GOOG ) will also showcase updates to its AI features and Android software, The Verge reported, citing the event invitation. Price:...

Savara's Phase 3 Trial for Molgramostim Nebulizer Solution Meets Primary Endpoint; Shares Rise Pre-Bell

Jun 26, 2024

07:37 AM EDT, 06/26/2024 (MT Newswires) -- Savara (SVRA) said Wednesday that the phase 3 IMPALA-2 clinical trial assessing the efficacy and safety of Molgramostim in adult patients with autoimmune pulmonary alveolar proteinosis met its primary endpoint. The trial showed statistically significant improvement in percent predicted diffusing capacity of the lungs for carbon monoxide versus placebo at week 24 and...

Titan Mining Completes Phase 1 Drilling at Kilbourne Graphite Project in New York State

Jun 26, 2024

07:31 AM EDT, 06/26/2024 (MT Newswires) -- Titan Mining ( TIMCF ) said Wednesday that it completed the phase one drilling at its Kilbourne graphite project within the Empire State mine in upstate New York. Results include 143.5 feet assaying 3.6% graphitic carbon, 92.8 feet assaying 3.5% graphitic carbon and 89.1 feet assaying 3.1% graphitic carbon. The first phase of...

General Mills Fiscal Q4 Adjusted Earnings, Net Sales Fall

Jun 26, 2024

07:35 AM EDT, 06/26/2024 (MT Newswires) -- General Mills ( GIS ) reported fiscal Q4 adjusted earnings Wednesday of $1.01 per diluted share, down from $1.12 a year earlier. Analysts polled by Capital IQ expected $0.99. Net sales for the quarter ended May 26 were $4.71 billion, down from $5.03 billion a year earlier. Analysts surveyed by Capital IQ expected...